This website uses cookies to enhance the user experience.
V

VIER HOLDING AS988 296 139

Counseling
Limited company
Kamskjellveien 30 4310 HOMMERSÅK, Norge

VIER HOLDING AS

Keywords

consultingguidanceassistancemanagement issuesstrategicorganizationalreorganizationbusiness procedureschange managementcost reductionpersonnelremunerationpension strategiesproduction planningcontrol planninglobbyingaccounting procedurescost accountingbudget control proceduresrationalizationcontrolmanagement information

Organization

Chairman of the board
GV
Years since formation
19 years
since Jun 6, 2005
Type
Limited company
VAT registered
No
Number of employees
0

Ownership

Number of shares and share classes
100
1 share class
Total number of shareholders
1
person

Financials

Total operating income 2023
85,702
NOK
Annual total result 2023
-593,189
NOK
Total equity 2023
5,309,640
NOK
Last update: Aug 29, 2024

Management

Board

NameRoleShares
GV
Business Manager, Chairman
100 %
directly
Alternate Member-

Others

NameRoleShares
Ø
ØKO REGNSKAP AS
Accountant-

Top 10 individual shareholders

NameRoleShares
GV
Business Manager, Chairman
100 %
directly
Last update: Nov 1, 2023

Ownership

Company shareholders

NameShare classNumber of sharesShare
GV
Ordinary shares
100
100 %

Shares owned by the VIER HOLDING AS

NameShare classNumber of sharesShare
V
VVD EXTRUSION AS
Ordinary shares
10,000
33.33 %
B
BRIS NÆRINGSEIENDOM AS
Ordinary shares
4,625
30.83 %
S
SMARTSEAL AS
NO0010288681
2,173,732
0.21 %
P
PHOTOCURE ASA
NO0010000045
26,000
0.1 %
NO0010813843
108,206
0.02 %
A
NO0010014632
8,000
0.02 %
E
EIDESVIK OFFSHORE ASA
NO0010263023
16,000
0.02 %
O
ONCOINVENT ASA
NO0010779341
3,000
0.02 %
U
ULTIMOVACS ASA
NO0010851603
7,000
0.02 %
S
SOLSTAD OFFSHORE ASA
NO0003080608
12,000
< 0.01 %
N
NEL ASA
NO0010081235
500
< 0.01 %
N
NEXT BIOMETRICS GROUP ASA
NO0010629108
10,000
< 0.01 %
L
LYTIX BIOPHARMA AS
NO0010405780
1,000
< 0.01 %
NO0010284318
802
< 0.01 %
L
LIFECARE ASA
NO0010591191
3,000
< 0.01 %
N
NYKODE THERAPEUTICS ASA
NO0010714785
3,000
< 0.01 %
B
BERGENBIO ASA
NO0010650013
292,000
< 0.01 %
T
THOR MEDICAL ASA
NO0010597883
6,700
< 0.01 %
C
CIRCIO HOLDING ASA
NO0013033795
700
< 0.01 %
Last update: May 24, 2024

Financials

in NOK

Summary

Year202320222021
Total operating income
85,702
3,000
80,400
Annual Total Result
-593,189
-144,686
92,601
Total assets
5,312,640
6,495,183
6,774,391
Total liabilities
3,000
592,354
258,276
Total equity
5,309,640
5,902,829
6,516,115

P&L

Year202320222021
Total operating income
85,702
3,000
80,400
Total operating costs
113,677
136,188
130,418
Operating result
-27,975
-133,188
-50,018
Financial income/costs
-565,214
-11,498
142,618
Profit before tax
-593,189
-144,686
92,601
Total tax & extraordinary income/cost
0
0
0
Annual Total Result
-593,189
-144,686
92,601

Balance overview

Year202320222021
Total fixed assets
651,711
1,524,367
1,722,141
Total current assets
4,660,929
4,970,817
5,052,250
Total assets
5,312,640
6,495,183
6,774,391
Short term debt
3,000
471,600
74,014
Long term debt
0
120,754
184,262
Total liabilities
3,000
592,354
258,276
Contributed capital
104,000
104,000
104,000
Retained earnings
5,205,640
5,798,829
6,412,115
Total equity
5,309,640
5,902,829
6,516,115
Total equity and liabilities
5,312,640
6,495,183
6,774,391

Classification

Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
M
Main industrial area
Professional, scientific and technical activities
70
Activity
Activities of head offices; management consultancy activities
70.2
Main industrial group
Management consultancy activities
70.22
Industrial group
Business and other management consultancy activities
70.220
Industrial group
Business and other management consultancy activities